http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2945196-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4f7649f9c61c35bd16f89658e27aba9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-135
filingDate 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0891ac738b384336f8191fb29a97ebfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09fbb3c727dd0f56a4b8876316e98296
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dce8307dd1e0553835c23a0daf48e60d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1121b6ee2755c9c1640a906851d78eac
publicationDate 2015-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2945196-A1
titleOfInvention Treatment of parkinson's disease through arfgap1 inhibition
abstract Methods are provided for the treatment of Parkinson's disease (PD) in patients bearing mutations in the LRRK2 gene. A therapeutically effective amount of piperazine derivative compounds are employed to inhibit the biological activity of ArfGAP1, inhibition that counteracts the deleterious effects of mutations in, or increased expression of, the LRRK2 protein.
priorityDate 2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526829
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID79705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422356054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID66251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426459271
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID402889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412478856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8434
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40487
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID77011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10352524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7096
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7416
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID233328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414939035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12485890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20240
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26286
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7

Total number of triples: 59.